<p>Tumors from 383 newly diagnosed diffuse large B cell lymphoma were included in this study. Tumor DNA was extracted from formalin-fixed, paraffin embedded (FFPE) tissue sections, germline DNA was extracted from blood, and whole exome sequencing (WES) of all samples (n=340 tumor normal pairs) was performed using the Agilent SureSelect XT AllExon v5 + UTR kit and sequencing was carried out on an Illumina NovaSeq, 100 x 2 paired end reads. Tumor RNA (n=321) was extracted from formalin-fixed, paraffin embedded (FFPE) tissue sections and RNA sequencing was performed using the Illumina TruSeq RNA Exome Kit (Illumina) for library preparation, sequencing platform HiSeq 4000, 100 x 2 paired end reads.</p>

Genomic Analysis of Diffuse Large B Cell Lymphoma

1 selected publication including "Multiomic analysis identifies a high-risk signature that predicts earl..." (7 citations)

Genomic Analysis of Diffuse Large B Cell Lymphoma

Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL